Sepofarsen
Sepofarsen Uses, Dosage, Side Effects, Food Interaction and all others data.
Sepofarsen is under investigation in clinical trial NCT03913143 (A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)).
| Trade Name | Sepofarsen |
| Generic | Sepofarsen |
| Sepofarsen Other Names | Sepofarsen |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Sepofarsen
